Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/08/2009US20090253724 Therapeutic or prophylactic agent for leukemia
10/08/2009US20090253723 Protein kinase inhibitors
10/08/2009US20090253722 Aqueous pharmaceutical formulation
10/08/2009US20090253721 Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor
10/08/2009US20090253720 Antifolate compositions
10/08/2009US20090253719 Crystalline salt forms of antifolate compounds and methods of manufacturing thereof
10/08/2009US20090253718 Pharmaceutical Compounds
10/08/2009US20090253717 Inhibitors of p97
10/08/2009US20090253716 Amino-imidazolones for the inhibition of beta-secretase
10/08/2009US20090253715 Heteroaryl-containing isoflavones as aromatase inhibitors
10/08/2009US20090253714 Methods of reducing risk of infection from pathogens
10/08/2009US20090253713 Small Molecule Compositions for Sexual Dysfunction
10/08/2009US20090253712 Aqueous solvent system for solubilization of azole compounds
10/08/2009US20090253711 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/08/2009US20090253710 NMDA Receptor Antagonists for Neuroprotection
10/08/2009US20090253709 Synthesis, telomerase inhibition and cytotoxic studies on 2,7-disubstituted anthraquinone derivatives
10/08/2009US20090253707 Heteroannelated anthraquinone derivatives and the synthesis method thereof
10/08/2009US20090253706 Methods and Compositions for the Treatment of Rheumatoid Arthritis and Other Inflammatory Diseases
10/08/2009US20090253705 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009US20090253704 PYRROLOTRIAZINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/08/2009US20090253703 Organic compounds
10/08/2009US20090253702 Fast acting naratriptan composition
10/08/2009US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders
10/08/2009US20090253700 N-'4-4(4-morpholinyl) phenyl!- '(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors
10/08/2009US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use
10/08/2009US20090253698 Brain, Spinal and Nerve Injury Treatment
10/08/2009US20090253697 Novel Indole Derivatives, Preparation Thereof as Medicinal Products and Pharmaceutical Compositions, and Especially as KDR Inhibitors
10/08/2009US20090253696 Substituted pyrido(3,2-d) pyrimidines and pharmaceutical compositions for treating viral infections
10/08/2009US20090253695 Hydroxyalkyl Substituted Imidazonaphthyridines
10/08/2009US20090253694 Fused hetrocyclic compounds
10/08/2009US20090253693 2H-BENZO[b][1,4]OXAZIN-3(4H)-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/08/2009US20090253692 Crystalline form of n-[[4-fluoro-2-(5-methyl-1h-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sodium salt monohydrate
10/08/2009US20090253691 Trisubstituted 1,2,4-triazoles
10/08/2009US20090253690 N-[3-(1-piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine; cardiovascular disorders; treating dysfunction of endothelial cells
10/08/2009US20090253689 Organic Compounds
10/08/2009US20090253688 Semicarbazide derivatives as kinase inhibitors
10/08/2009US20090253687 Fused Heterocyclic Compounds and Their Use as Mineralocorticoid Receptor Ligands
10/08/2009US20090253686 Unsolvated benzodiazepine compositions and methods
10/08/2009US20090253685 Product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090253683 7-membered ring compound and method of production and pharmaceutical application thereof
10/08/2009US20090253682 Heterocyclic derivatives for modulation of calcium channels
10/08/2009US20090253681 HIV Integrase Inhibitors
10/08/2009US20090253680 Selected cgrp-antagonists, processes for preparing them and their use as pharmaceutical compositions
10/08/2009US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
10/08/2009US20090253678 Macrocyclic pyrimidine derivatives
10/08/2009US20090253677 HIV Integrase Inhibitors
10/08/2009US20090253676 Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes
10/08/2009US20090253675 Pharmaceutical formulation
10/08/2009US20090253674 Substituted Triazole Derivatives As Oxytocin Antagonists
10/08/2009US20090253673 Substituted Pyrazoles as Ghrelin Receptor Antagonists
10/08/2009US20090253672 Cathepsin Cysteine Protease Inhibitors
10/08/2009US20090253671 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
10/08/2009US20090253670 nicotinic receptor modulators such as N-[3-(1H-pyrrol-1-yl)benzyl]-4-[(trifluoromethyl)thio]benzamide, useful for treating and preventing a condition or disorder affecting cognition, neurodegeneration and schizophrenia
10/08/2009US20090253669 Substituted Sulfonamide Compounds
10/08/2009US20090253668 such as N-[(2,4-Dihydroxyphenyl)ethylidene]cysteine zinc salt for topical application; antiaging agents, antigreying agents
10/08/2009US20090253667 18 ,21-Didesoxymacbecin Derivatives for the Treatment of Cancer
10/08/2009US20090253666 Composition comprising sarsasapogenin
10/08/2009US20090253665 Method of treatment of disease using an adenosine a1 receptor antagonist and an aldosterone inhibitor
10/08/2009US20090253664 Combination andolast/glucocorticoids
10/08/2009US20090253663 Skin external preparation containing triterpenic acid
10/08/2009US20090253662 Genetic risk assessment in heart failure: impact of genetic variation of aldosterone synthase promoter polymorphism
10/08/2009US20090253661 Ocular agents
10/08/2009US20090253660 Minocycline Compounds and Methods of Use Thereof
10/08/2009US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor
10/08/2009US20090253658 Fat Accumulation Inhibitor
10/08/2009US20090253657 with associated osteoporosis in horses; two to five intramuscular injections within a period of up to 3 consecutive days
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009US20090253655 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
10/08/2009US20090253654 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
10/08/2009US20090253653 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
10/08/2009US20090253652 Phosphate-binding chitosan and uses thereof
10/08/2009US20090253651 Drug delivery system based on regioselectively amidated hyaluronic acid
10/08/2009US20090253650 Teat antiseptic prepared from polysaccharide gel with bactericidal and immuno-stimulating activity isolated from durian fruit-rind
10/08/2009US20090253649 Agents Containing Folic Acid, Vitamin B6 and Vitamin B12, and the Use Thereof
10/08/2009US20090253648 Tricyclic-Nucleoside Compounds for Treating Viral Infections
10/08/2009US20090253647 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
10/08/2009US20090253646 Pan-selectin inhibitor with enhanced pharmacokinetic activity
10/08/2009US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue
10/08/2009US20090253644 Radiosensitizer
10/08/2009US20090253643 Equol level regulator
10/08/2009US20090253642 Mimicking the metabolic effects of caloric restriction by administration of glucose anti-metabolites
10/08/2009US20090253620 Methods and compositions for treating gastrointestinal radiosensititivity in a subject
10/08/2009US20090253619 Novel peptide involved in energy homeostasis
10/08/2009US20090253617 Diagnosis and treatment of attentional disorders
10/08/2009US20090253616 Combination therapy for the treatment of cancer
10/08/2009US20090253615 No-modified hemoglobins and uses therefor
10/08/2009US20090253613 Solid-Fluid Composition
10/08/2009US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009US20090252817 Methods for the treatment or prevention of Diabetes Mellitus and other metabolic imbalances
10/08/2009US20090252810 Aryl/alkyl Succinic Anhydride-Hyaluronan Derivatives
10/08/2009US20090252807 Nanoparticulate and Controlled Release Compositions Comprising Prostaglandin Derivatives
10/08/2009US20090252806 Nanoparticulate tacrolimus formulations
10/08/2009US20090252804 Medical devices with an antibacterial polyurethaneurea coating
10/08/2009US20090252801 Process for the Preparation of Micronised Sterile Steroids
10/08/2009US20090252797 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
10/08/2009US20090252794 Tablet
10/08/2009US20090252793 Pharmaceutical compositions
10/08/2009US20090252792 method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides
10/08/2009US20090252791 Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
1 ... 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 ... 7860